China launches crackdown on drug industry

by Joe Mcdonald

(AP)—China announced a crackdown Wednesday on misconduct in its drug market, stepping up pressure on the problem-prone industry while it pursues a bribery investigation of GlaxoSmithKline.

The six-month crackdown is aimed at stamping out unauthorized drug production, improper online drug retailing and sales of fake traditional Chinese medicines, the State Food and Drug Administration said.

"We must resolutely punish illegal acts, resolutely close illegal enterprises and firmly recall problematic products," a deputy director of the agency, Wu Zhen, said in a statement on its website.

The announcement came two days after Chinese police accused GSK employees of conducting a multimillion-dollar campaign to encourage doctors to prescribe its medications. The statement did not mention the British .

The new Chinese leadership that took power in November has promised to improve China's health system and reining in surging costs of medicine and medical care that are fueling public frustration.

China has suffered repeated scandals over fake or shoddy medications, some of which caused deaths and injuries. Regulators have launched repeated crackdowns on false advertising and other violations, but with limited success.

From July through December, investigators will examine manufacturers, markets, clinics and online stores, the agency said.

The police ministry said this week that GSK employees paid to doctors and officials of hospitals, medical associations and the government to encourage use of its medications.

According to Chinese news reports, police say the employees funneled as much as 3 billion yuan ($490 million) through travel agencies and consulting firms to hide the source of bribes. Police said four employees including a vice president of GSK's China unit have been detained.

The official Xinhua News Agency said the scheme appeared to be aimed at evading GSK's internal controls meant to prevent bribery.

On Tuesday, state television showed one of the detained GSK employees describing how he paid bribes to government officials to win support for use of the company's medications.

Also Wednesday, a Commerce Ministry spokesman warned that misconduct by manufacturers would be punished.

"Whether they are domestic or foreign-invested enterprises, if they violate Chinese law, they will be subject to legal sanctions and bear responsibility," said spokesman Shen Danyang at a news briefing.

Meanwhile, the Cabinet's planning agency is investigating production costs at 60 Chinese and foreign pharmaceutical manufacturers, according to state media, possible as a prelude to revising state-imposed price caps on key medications.

The government also is investigating possible price-fixing by foreign milk suppliers.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Chinese police say Glaxo employees bribed doctors

Jul 11, 2013

China's police ministry accused executives of pharmaceutical supplier GlaxoSmithKline on Thursday of conducting a large and long-running bribery campaign to persuade doctors to prescribe drugs.

Chinese police probe kickbacks by Foxconn managers

Jan 10, 2013

(AP)—Hon Hai Precision, a leading maker of iPhones and other high-tech gadgets, has said it is working with Chinese police probing allegations that its employees solicited kickbacks from suppliers.

Recommended for you

Doctor behind 'free radical' aging theory dies

Nov 25, 2014

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.